argenx SE ( ARGNF) - Stock Earnings
ARGNF Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| July 23, 2026 AfterMarket | — / — | — | — / — | — |
ARGNF Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 344.3 million USD | 1.1 billion USD |
| 2025Q4 | 533.0 million USD | 1.3 billion USD |
| 2026Q1 | 366.0 million USD | 1.3 billion USD |
| 2026Q2 Est. | — | — |
| 2026Q4 Est. | — | — |
ARGNF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -295.1 million USD | 1.2 billion USD |
| 2024 | 833.0 million USD | 2.2 billion USD |
| 2025 | 1.3 billion USD | 4.2 billion USD |
| 2026 Est. | — | — |
ARGNF
Price: $900
52 week price:
Earnings Per Share: 22.49 USD
P/E Ratio: 35.71
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 51.7 billion